The Voice in the Ear -- Burt's Blog
<< To Homepage >>
<<Archives>>

September-October 2011 Archives:

 

October 5, 2011 -- 12:10pm EDT

In Memoriam: J. Willis Hurst, MD
J. Willis Hurst, MD
J. Willis Hurst, MD
(1920-2011)
Sad news out of Atlanta that Dr. J. Willis Hurst passed away on October 1 after a brief illness, a few weeks short of his 91st birthday. Hurst was a major figure in cardiology worldwide, having served as Professor and Chairman of the Department of Medicine at the Emory University School of Medicine for 30 years, and the author of "Hurst's The Heart", undisputedly the "bible" of cardiology, which is in its 13th edition and has been translated into more than five languages. It is considered to be the most widely used cardiology textbook in the world. I know that every cardiologist's office I've ever been in (and that's a lot) has "Hurst's The Heart" prominently displayed on the bookshelf.

Above all he was a teacher. Countless cardiologists went through his classes at Emory and he shaped the views and outlook of many thousands of physicians. You can read more about Dr. Hurst in a letter from his colleagues, posted on the Emory website. He was a Fellow of Dr. Paul Dudley White, considered the founder of American academic cardiology, and Hurst served as President Lyndon Johnson's personal cardiologist for 18 years.

But Hurst also had a hand in fostering what became a revolution in cardiology.

 

Zurich PTCA Course 1980
Back in 1979, Emory cardiologist Dr. Spencer B. King, III traveled to Zurich to attend the early courses of Dr. Andreas Gruentzig to learn about his controversial new procedure called "percutaneous transluminal coronary angioplasty". King befriended Gruentzig who expressed his concern that, unless he could keep control over the spread of this new procedure, it could be destroyed, if it were not done carefully.

 

Share This Story:
Email Bookmark and Share
Interest was growing rapidly and Gruentzig was looking to move to the U.S. to establish a teaching center. King suggested Emory and that is where Gruentzig landed. With significant support from Emory and the Woodruff Health Center, Gruentzig expanded the live demonstration course and, from 1980-85 in Atlanta, he personally trained the first wave of interventional cardiologists, and established the professional, scientific and ethical benchmarks of that subspecialty.

J. Willis Hurst, as Chairman of the Department, was instrumental in meeting Gruentzig's needs, both academically and, well...check out the short video clip below. I had the honor of interviewing Hurst for my documentary, "PTCA: A History" and he told me what Gruentzig asked for in order to come to Emory.

Video not loaded
J. Willis Hurst, MD discusses bringing Andreas Gruentzig,
the inventor of coronary angioplasty, to Emory (:55)

« permalink »          « send comment »          « back to top »

 

September 23, 2011 -- 11:20am EDT

Cross-Country Training for Transradial Wrist Angioplasty
Duke Transradial LogoHaving an coronary angiogram or heart stent placed via the wrist approach is common in Europe. India and Japan -- much less so in the U.S. -- even though the wrist (transradial) approach offers lower complications and higher patient comfort. Some studies have even shown that the radial approach, with its significantly lower bleeding complications, is superior in treating heart attacks (STEMI) since those patients need to be on high levels of anticoagulation meds.

Share This Story:
Email Bookmark and Share

So why are only 5% of U.S. procedures done via the wrist while figures in other countries run 50-80%? One reason has been training. In the U.S. cardiology fellows are trained in the femoral (leg/groin) approach, because that's what's practiced at their hospitals. So it's been a self-perpetuating practice.

But this is changing. Rapidly.This fall no less than eight major training courses in the transradial technique were scheduled: from North Carolina to San Francisco (you can see these on Angioplasty.Org's list of upcoming transradial approach training courses) -- more than were available during an entire year, maybe two, just a short while ago.

Next up on October 14 is a one-day course in San Francisco, the Transradial Intervention Program (TRIP) that since last November has been held at a number of centers by the Society for Cardiovascular Angiography and Interventions (SCAI). The following weekend of October 20-21 is the first advanced two-day course being run by Duke Clinical Research Institute, which also conducted a one-day course last weekend.

November brings a course at the Mid-America Heart Institute in Kansas City, MO and then an afternoon of over 20 presentations at the TCT 2011 meeting in San Francisco, the largest annual gathering of interventional cardiologists in the U.S.

Patients and physicians who want to learn more about this growing technique can read more about it at Angioplasty.Org's Transradial Access Center.

« permalink »          « send comment »          « back to top »

 

September 8, 2011 -- 6:45pm EDT

Transradial Angioplasty Training in Las Vegas
Wynn/Encore Hotel, Las VegasThis weekend Richard R. Heuser, MD, FSCAI and John E. Lassetter, MD, FSCAI of St. Luke's Hospital and Medical Center in Phoenix, Arizona will be conducting a one-day course in transradial (wrist) angioplasty at the Wynn/Encore Hotel in Las Vegas, Nevada. But the games of chance will be relegated to the casinos because, as Dr. Heuser recounts in his exclusive interview with Angioplasty.Org, the wrist approach to diagnostic and interventional coronary procedures is safer for patients, more comfortable for patients and (trumpet fanfare) has the potential to reduce costs of healthcare as well.

Share This Story:
Email Bookmark and Share

And Dr. Richard Heuser has been performing PCIs since the beginning days of balloons and stents -- so his perspective on why the transradial approach offers significant benefits is definitely of import to cardiologists across the U.S.

As he states in his interview, if you utilize the transradial approach:

"...you'll reduce your likelihood of vascular complications by four times, and if you look at the most comprehensive head to head trial, the RIVAL trial, you'll see that you will not give up anything in terms of safety and efficacy. You will give up the fact that you will have more blood transfusions and more vascular complications going femorally and, if you look at the sites that were high volume radials, they actually had an improvement in hard outcomes -- that's MI, and morbidity, and mortality. So I think that if I could be so bold as to say, you're doing your patients a disservice if you don't at least consider radial an option in patients... even to the point that they request it...because the reality is, they are going to be requesting it."

Read the entire interview here....

« permalink »          « send comment »          « back to top »